Shuttle Pharmaceuticals
SHPH
2 hedge funds and large institutions have $39.2K invested in Shuttle Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
13% more capital invested
Capital invested by funds: $34.6K → $39.2K (+$4.63K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
33% less funds holding
Funds holding: 3 → 2 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$63.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$16.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$12.3K |
| 3 |
VF
Virtu Financial
New York
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
1
HRT Financial
New York
| $34K | +$63.2K | +103 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $5.13K | +$9.2K | +15 | New |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $84 | – | – | – |
|
4
Bank of America
Charlotte,
North Carolina
| $12 | – | – | – |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$16.9K | -21 | Closed |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| – | -$12.3K | -15 | Closed |
|
|
VF
7
Virtu Financial
New York
| – | -$5K | -6 | Closed |
|
SHPH Hedge Fund Activity: Q3 2024 in Review
2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q3 2024, worth a combined $39.2K — up 13% from $34.6K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of SHPH and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $63.2K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $16.9K sold.
- 2 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q3 2024, down from 3 in Q2 2024.
- Funds reported $39.2K of Shuttle Pharmaceuticals stock for Q3 2024, up 13% quarter-over-quarter.
- 2 funds opened new Shuttle Pharmaceuticals positions in Q3 2024 and 3 closed out, a net change of -1 holder.
- The largest Shuttle Pharmaceuticals buyer in Q3 2024 was HRT Financial, an estimated $63.2K added.
- The largest Shuttle Pharmaceuticals seller in Q3 2024 was Two Sigma Securities, an estimated $16.9K sold.
Based on aggregated 13F filings for Q3 2024.